.jpg)
Our Executive Team
With over 100 years of combined experience, our team of seasoned CEOs, COOs, CFOs, medical professionals, and scientists brings strategic leadership in business management, M&A, and growth planning.
Jane C. Andrews, Ph.D.
Founder & CEO
Dr. Andrews is a recognized leader in Life Sciences, Regenerative Medicine, and Cell Therapy, with a deep understanding of both the technological and operational aspects of these industries. Under her leadership, Cell Bridge Strategies bridges the gap between science and business, helping companies leverage their strengths to capitalize on market opportunities. Her expertise includes developing strategies, executing tactics, building financial and market models, and identifying potential partnerships, funding, or M&A opportunities. Dr. Andrews also creates advisory boards to provide additional guidance to clients as they navigate their growth.
Dr. Andrews has built a global network of Life Science and Regenerative Medicine experts, providing her clients with invaluable access to thought leaders and influencers in the field. Throughout her career, she has been at the intersection of science and business, with a focus on accelerating the growth of biomedical technologies. She has held numerous positions, including Senior Global Healthcare & Life Science Consultant at Frost & Sullivan, where she worked with clients ranging from Big Pharma and CDMOs to academic investigators. She has also served as Senior Director of Strategic Marketing at BioBridge Global and NASA Senior Scientist for Lockheed Martin Space Operations.
In addition to her leadership roles, Dr. Andrews is a sought-after lecturer at industry events such as the World Stem Cell Summit, Mixii Bio, and The World Advanced Therapies & Regenerative Medicine Congress & Expo. She has received multiple awards for her work with NASA, honorariums from NIH and The Smithsonian Institute, and has written numerous published papers and proprietary reports. Dr. Andrews earned her BS, MS, and Ph.D. from the University of Wisconsin–Madison, followed by a Postdoctoral Fellowship at Penn State University.
Dr. Andrews is also a core team member of Cell One Partners and serves on the Industry Advisory Board for the Healthspan Action Coalition. These affiliations further reflect her commitment to advancing the fields of cell therapy and healthy aging. Through Cell Bridge Strategies and her broader industry involvement, she continues to empower companies by connecting innovation with opportunity and turning scientific potential into market success.
Neil Kellen
Principal Consultant – Strategy & Finance & CFO
As a key leader at Cell Bridge Strategies, Neil Kellen brings extensive executive-level expertise in business management, financial strategy, and market positioning. With a proven track record in mergers & acquisitions, investor and bank relations, legal strategy, manufacturing, and sales channels, he plays a critical role in guiding clients toward sustainable growth and financial success.
Neil specializes in financial and strategic analysis tailored to companies in the Life Sciences sector. His expertise helps businesses navigate complex financial landscapes, including preparing for partnerships, acquisitions, or IPOs. He develops comprehensive market and financial models to assess new product introductions and formulates multi-year pricing strategies that balance market penetration, profitability, and competition.
With Cell Bridge Strategies at the forefront, Neil’s leadership ensures clients are positioned for long-term success in an evolving industry. His ability to merge financial foresight with strategic execution makes him an invaluable asset to both the firm and the clients it serves.
Keith Parent
Advisor & Principal Consultant
As a trusted advisor and principal consultant at Cell Bridge Strategies, Keith Parent brings over 35 years of leadership and technology expertise in the Life Sciences industry. Renowned for his ability to develop and support IT systems for pharmaceutical, biotech, and medical device companies, Keith plays a critical role in helping organizations navigate regulatory complexities and maintain compliance with Good System Practices (GSPs).
With a Master of Science in Computer Science from Rensselaer Polytechnic Institute and a Bachelor of Science in Computer Science from Siena College, Keith has been instrumental in implementing and managing enterprise-level systems for pre-clinical and clinical organizations. His experience spans the oversight of 5,000+ servers worldwide, supporting critical infrastructures such as CTMS, Global Submission and eCTD systems, FDA Gateways, Adverse Event Reporting systems, and Clinical Trial Registries—serving over 100,000 users across various clinical settings.
A recognized thought leader, Keith has provided strategic IT consulting for leading pharmaceutical companies, including Pfizer for over 27 years. His insights have shaped industry standards, and he is a sought-after speaker at major Life Science conferences. At Cell Bridge Strategies, Keith’s unparalleled expertise in technology, compliance, and innovation positions clients for success in an evolving regulatory landscape.
Preveen Ramamoorthy, Ph.D.
Advisory Board Member & Principal Consultant
As a global leader in Precision Medicine, Cell & Gene Therapy, Biologics, and Medical Devices, Dr. Preveen Ramamoorthy brings over 15 years of experience in driving innovation and patient-centric advancements in the Life Sciences industry. A clinician by wiring and a biologist by training, he is a visionary executive, entrepreneur, and academician dedicated to translating cutting-edge research into impactful therapies.
Dr. Ramamoorthy’s expertise spans biologics development, precision medicine diagnostics, and breakthrough medical technologies. He has led initiatives in vaccines, monoclonal antibodies (MAbs), genomics, proteomics, immunoassays, multi-omics biomarkers, blood transfusion, immunotherapy, stem cell therapy, and CAR-T cell therapy. His ability to bridge scientific innovation with commercial strategy makes him an invaluable asset to Cell Bridge Strategies and the clients we serve.
With a proven track record in R&D leadership, clinical operations, AI-driven data analytics, and therapeutic development, Dr. Ramamoorthy has held executive roles including President of Clinical Diagnostics and Head of R&D at HealthTell/iCarbonX, Vice President of Global Scientific & Clinical Affairs at Terumo BCT, and Vice President of Clinical Diagnostics at Strand Life Sciences. At Cell Bridge Strategies, his deep industry knowledge and strategic collaboration experience empower companies to accelerate product development, navigate regulatory landscapes, and achieve commercial success in an evolving healthcare market.
Michael J. Fiske, M.S.
Principal Consultant
With over 30 years of experience in the biotechnology industry, Michael J. Fiske is a highly accomplished scientist and executive specializing in early-phase development of protein and cell therapy products. His expertise spans the entire product development lifecycle, from candidate discovery and characterization to clinical-scale GMP production and regulatory compliance. His background includes work in advanced cellular therapies, industrial enzymes, metabolic pathway intermediates, diagnostics, vaccines, and therapeutic proteins—making him a key asset to Cell Bridge Strategies and the clients we serve.
Michael is currently the Vice President of Manufacturing Sciences at Scorpion Biological Services, where he oversees a multi-use, cGMP-compliant contract manufacturing facility focused on the development and production of advanced therapies. His technical expertise covers protein chemistry, analytical biochemistry, process development, and cGMP operations management—ensuring that therapies move seamlessly from research into production.
At Cell Bridge Strategies, Michael helps clients navigate complex biomanufacturing and regulatory challenges, offering deep expertise in facility design, process development, analytical methods, technology transfer, and cGMP manufacturing. He also supports clients in preparing regulatory submissions and engaging with regulatory agencies to streamline approvals. His ability to bridge scientific innovation with operational execution ensures that life-changing therapies reach patients efficiently and safely.
Education: M.S., Biochemistry, SUNY Binghamton.
Rick Stockton
Principal Consultant
Rick Stockton brings a unique blend of process engineering, manufacturing, and device design expertise to Cell Bridge Strategies. As a seasoned consultant and the Principal at J.R. Stockton Consulting, LLC, Rick specializes in guiding clients through facility planning, new product design, and scale-up processes. His ability to conceptualize and execute three-dimensional solutions makes him a critical asset for companies navigating complex manufacturing and development challenges. Whether it’s facility buildout, equipment design, or process validation, Rick’s strategic approach ensures efficiency, functionality, and long-term scalability.
With deep experience in product and system development, Rick excels in transforming ideas into tangible, market-ready solutions. He works closely with clients to refine existing concepts and enhance them with the practical elements necessary for production, deployment, and maintenance. His expertise spans ideation, invention, and full-scale product design at the corporate level, making him an invaluable resource for companies seeking to bring innovative solutions to life.
Rick’s work revolves around optimizing design to bridge the gap between concept and commercialization. He focuses on turning initial ideas into validated prototypes, transitioning prototypes into reliable, cost-effective products that can be rapidly manufactured, and ensuring seamless integration between products, users, and production systems. His expertise extends to human and machine interface design, facility layout optimization, and comprehensive system implementation, enabling organizations to scale efficiently and successfully.
Jan Rodriguez, RN, CCRA
Senior Consultant
Jan Rodriguez is a highly experienced Registered Nurse and Certified Clinical Research Associate (CCRA) with two decades of expertise in clinical trial management and monitoring. Her extensive background in overseeing international and national clinical trials across Phase I-IV for drugs, medical devices, and biologics makes her an essential asset to Cell Bridge Strategies. Jan’s ability to navigate the complexities of clinical research ensures that clients receive expert guidance in study execution, regulatory compliance, and strategic oversight of trial operations.
Throughout her career, Jan has played a pivotal role in clinical trial success by managing critical aspects such as clinical monitoring, project coordination, regulatory adherence, and contract negotiations. She has led study start-ups, streamlined SAE reporting and reconciliation processes, and developed study-specific tools to enhance trial efficiency. Her keen attention to detail and deep understanding of regulatory frameworks help clients mitigate risks and ensure trials are conducted according to the highest industry standards.
Jan’s expertise spans a diverse range of therapeutic areas, including hematology/oncology, analgesia, cardiology, CNS, diabetes, endocrinology, gene therapeutics, infectious disease, pediatrics, orthopedic and skeletal diseases, and medical devices. Her ability to adapt to evolving clinical landscapes and her dedication to patient-centric research make her a trusted advisor for organizations aiming to bring innovative therapies to market with precision and compliance.
Nadav Ofir
Principal Consultant, Research and Strategy
Nadav Ofir is an accomplished market research expert with a diverse and multi-disciplinary background in healthcare technologies. With over 100 market research projects under his belt, Nadav has partnered with leading companies such as Roche, Philips, Insightec, MeMed, BioView, Brainsway, Inspira, Nyxoah, LiberDi, and SpacePharma. His vast experience in providing actionable insights and strategic guidance has helped businesses navigate complex markets and achieve significant growth in the healthcare and life sciences sectors.
Prior to his role at Cell Bridge Strategies, Nadav served as the Head of Consulting and Research at Frost & Sullivan, where he specialized in market entry strategies, competitive intelligence, and business development. His expertise in analyzing market trends, identifying growth opportunities, and conducting thorough competitive assessments has been instrumental in driving the success of numerous clients. His research has supported companies in developing robust strategies to capture market share, secure investments, and expand their reach within the healthcare landscape.
In addition to his consulting work, Nadav is a respected lecturer in executive MBA MedTech programs, where he shares his expertise on business planning and market research. His ability to translate complex market dynamics into clear, actionable insights makes him a trusted advisor for organizations looking to enhance their strategic decision-making and business development efforts. Nadav’s unique blend of research expertise and practical experience positions him as a key asset to Cell Bridge Strategies’ clients.
Hilal Cura
Principal Consultant, Healthcare
Hilal Cura is a highly skilled healthcare consultant with a proven track record in advancing breakthrough medical technologies and healthcare services. As a Principal Healthcare Consultant at Cell Bridge Strategies, she offers her extensive experience in market strategy, competitive intelligence, and go-to-market assessments, working with both global healthcare leaders and emerging MedTech startups. Hilal’s ability to analyze and strategize across diverse healthcare sectors makes her a key asset to clients looking to navigate complex healthcare landscapes and achieve strategic success.
Before joining Cell Bridge Strategies, Hilal served as a Senior Consultant at Frost & Sullivan, where she managed and authored nearly 70 in-depth reports focused on the EU-5 and U.S. markets. Her research has been instrumental in helping top-tier healthcare companies optimize market entry strategies, identify new opportunities, and position themselves effectively in an evolving MedTech ecosystem. Hilal’s comprehensive understanding of market dynamics, regulatory challenges, and competitive trends has provided valuable insights that enabled her clients to stay ahead in a fast-paced and competitive industry.
In her current role, Hilal continues to provide strategic guidance to healthcare organizations, leveraging her wealth of experience to support market positioning, product launches, and long-term growth initiatives. Her expertise in healthcare technologies and her strong background in market analysis make her an invaluable member of the Cell Bridge Strategies team. Whether working with global leaders or innovative startups, Hilal’s strategic insights empower clients to make informed decisions and drive sustainable success in the healthcare sector.